Literature DB >> 23440305

Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model.

Johannes Boltze1, Björn Nitzsche, Kathrin D Geiger, Heinz-Adolf Schoon.   

Abstract

Translational researchers and clinicians recommend the use of large animal models in preclinical stroke research. This represents an important part of a strategy aiming to prevent past translational failures in future therapeutic developments. Thirty-five Merino rams were subjected to sham surgery (n = 3), one-branch middle cerebral artery occlusion (MCAO, n = 8) or total MCAO (n = 24). Twelve animals from the latter group received intravenous administration of 4 × 10(6) autologous mononuclear bone marrow cells (BM MNC) per kilogram 24 h after total MCAO. Animals were sacrificed at day 49 post MCAO. Histological investigations were performed to reveal (1) the impact of different MCAO modalities on a cellular level and (2) the influence of BM MNC therapy following stroke. Clear differences between one-branch and total MCAO were observed histologically with results being comparable to those seen in human patients. BM MNC treatment reduced final lesion extension, lymphocytic infiltration and axonal degeneration after MCAO. The sheep model may represent a feasible tool for translational stroke research as pathohistological findings mimic the situation in humans. Histological evidence was found for beneficial impact of autologous BM MNC therapy. Further studies are needed to assess the neurofunctional impact of the approach in the gyrencephalic brain.

Entities:  

Keywords:  Brain ischaemia; Cell therapy; Large animal model; Neuroprotection; Stroke; Translational research

Year:  2011        PMID: 23440305      PMCID: PMC3574567          DOI: 10.1007/s12975-011-0101-5

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  48 in total

1.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy.

Authors:  David M Leistner; Ulrich Fischer-Rasokat; Jörg Honold; Florian H Seeger; Volker Schächinger; Ralf Lehmann; Hans Martin; Iris Burck; Carmen Urbich; Stefanie Dimmeler; Andreas M Zeiher; Birgit Assmus
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

2.  Selective staining of human dermal collagen. II. The use of picrosirius red F3BA with polarization microscopy.

Authors:  V S Constantine; R W Mowry
Journal:  J Invest Dermatol       Date:  1968-05       Impact factor: 8.551

3.  Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.

Authors:  Valeria Battistella; Gabriel R de Freitas; Lea Mirian Barbosa da Fonseca; Daniel Mercante; Bianca Gutfilen; Regina C S Goldenberg; Juliana Vieira Dias; Tais H Kasai-Brunswick; Eduardo Wajnberg; Paulo Henrique Rosado-de-Castro; Soniza V Alves-Leon; Rosalia Mendez-Otero; Charles Andre
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

4.  Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project.

Authors:  Peter L Kolominsky-Rabas; Peter U Heuschmann; Daniela Marschall; Martin Emmert; Nikoline Baltzer; Bernhard Neundörfer; Oliver Schöffski; Karl J Krobot
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

Review 5.  Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection.

Authors:  Ibrahim Kassis; Adi Vaknin-Dembinsky; Dimitrios Karussis
Journal:  Curr Stem Cell Res Ther       Date:  2011-03       Impact factor: 3.828

6.  Human cerebral infarct: a proposed histopathologic classification based on 137 cases.

Authors:  Hernando Mena; Diego Cadavid; Elisabeth J Rushing
Journal:  Acta Neuropathol       Date:  2004-10-26       Impact factor: 17.088

7.  Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.

Authors:  K R Lees; D Barer; G A Ford; W Hacke; V Kostulas; A K Sharma; T Odergren
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

Review 8.  Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke.

Authors: 
Journal:  Stroke       Date:  2008-12-18       Impact factor: 7.914

Review 9.  Inflammation as a therapeutic target in acute ischemic stroke treatment.

Authors:  Antonino Tuttolomondo; Riccardo Di Sciacca; Domenico Di Raimondo; Chiara Renda; Antonio Pinto; Giuseppe Licata
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

10.  PET study of changes in local brain hemodynamics and oxygen metabolism after unilateral middle cerebral artery occlusion in baboons.

Authors:  S Pappata; M Fiorelli; T Rommel; A Hartmann; C Dettmers; T Yamaguchi; H Chabriat; J B Poline; C Crouzel; L Di Giamberardino; J C Baron
Journal:  J Cereb Blood Flow Metab       Date:  1993-05       Impact factor: 6.200

View more
  8 in total

1.  Correcting for Brain Swelling's Effects on Infarct Volume Calculation After Middle Cerebral Artery Occlusion in Rats.

Authors:  Devin W McBride; Damon Klebe; Jiping Tang; John H Zhang
Journal:  Transl Stroke Res       Date:  2015-05-03       Impact factor: 6.829

2.  Exposure of the Pig CNS for Histological Analysis: A Manual for Decapitation, Skull Opening, and Brain Removal.

Authors:  Carsten R Bjarkam; Dariusz Orlowski; Laura Tvilling; Johannes Bech; Andreas N Glud; Jens-Christian H Sørensen
Journal:  J Vis Exp       Date:  2017-04-13       Impact factor: 1.355

3.  CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice.

Authors:  Jianping Wang; Xi Liu; Hong Lu; Chao Jiang; Xiaobing Cui; Lie Yu; Xiaojie Fu; Qian Li; Jian Wang
Journal:  Brain Behav Immun       Date:  2014-12-16       Impact factor: 7.217

Review 4.  Cell therapies: careful translation from animals to patients.

Authors:  Sean I Savitz
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

5.  Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke Model.

Authors:  Bing Yang; Kaushik Parsha; Krystal Schaar; XiaoPei Xi; Jaroslaw Aronowski; Sean I Savitz
Journal:  Transl Stroke Res       Date:  2016-03-20       Impact factor: 6.829

6.  A stereotaxic, population-averaged T1w ovine brain atlas including cerebral morphology and tissue volumes.

Authors:  Björn Nitzsche; Stephen Frey; Louis D Collins; Johannes Seeger; Donald Lobsien; Antje Dreyer; Holger Kirsten; Michael H Stoffel; Vladimir S Fonov; Johannes Boltze
Journal:  Front Neuroanat       Date:  2015-06-04       Impact factor: 3.856

7.  A Novel Ligustrazine Derivative T-VA Prevents Neurotoxicity in Differentiated PC12 Cells and Protects the Brain against Ischemia Injury in MCAO Rats.

Authors:  Guoling Li; Guoliang Li; Yufei Tian; Yuzhong Zhang; Ying Hong; Yingzhi Hao; Chunxiao Chen; Penglong Wang; Haimin Lei
Journal:  Int J Mol Sci       Date:  2015-09-09       Impact factor: 5.923

Review 8.  Translational models for vascular cognitive impairment: a review including larger species.

Authors:  Atticus H Hainsworth; Stuart M Allan; Johannes Boltze; Catriona Cunningham; Chad Farris; Elizabeth Head; Masafumi Ihara; Jeremy D Isaacs; Raj N Kalaria; Saskia A M J Lesnik Oberstein; Mark B Moss; Björn Nitzsche; Gary A Rosenberg; Julie W Rutten; Melita Salkovic-Petrisic; Aron M Troen
Journal:  BMC Med       Date:  2017-01-25       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.